Microbot Income Before Tax from 2010 to 2024

MBOT Stock  USD 0.99  0.01  1.02%   
Microbot Medical Income Before Tax yearly trend continues to be comparatively stable with very little volatility. Income Before Tax will likely drop to about -11.3 M in 2024. From the period from 2010 to 2024, Microbot Medical Income Before Tax quarterly data regression had r-value of  0.37 and coefficient of variation of (383.36). View All Fundamentals
 
Income Before Tax  
First Reported
1993-03-31
Previous Quarter
-2.5 M
Current Value
85 K
Quarterly Volatility
5.8 B
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 100.7 K, Interest Expense of 158.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 302, Dividend Yield of 58.41 or PTB Ratio of 3.9. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.
  
Check out the analysis of Microbot Medical Correlation against competitors.
For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Latest Microbot Medical's Income Before Tax Growth Pattern

Below is the plot of the Income Before Tax of Microbot Medical over the last few years. Income Before Tax which can also be referred as pre-tax income is reported on Microbot Medical income statement and is an important metric when analyzing Microbot Medical profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability. It is Microbot Medical's Income Before Tax historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbot Medical's overall financial position and show how it may be relating to other accounts over time.
Income Before Tax10 Years Trend
Slightly volatile
   Income Before Tax   
       Timeline  

Microbot Income Before Tax Regression Statistics

Arithmetic Mean(1,435,529,810)
Geometric Mean21,213,605
Coefficient Of Variation(383.36)
Mean Deviation2,652,400,825
Median(11,277,000)
Standard Deviation5,503,246,219
Sample Variance30285719T
Range21.3B
R-Value0.37
Mean Square Error28110858.7T
R-Squared0.14
Significance0.17
Slope457,317,106
Total Sum of Squares424000065.3T

Microbot Income Before Tax History

2024-11.3 M
2023-10.7 M
2022-13.2 M
2021-11.3 M
2020-9.2 M
2019-7.2 M
2018-7.2 M

About Microbot Medical Financial Statements

Microbot Medical shareholders use historical fundamental indicators, such as Income Before Tax, to determine how well the company is positioned to perform in the future. Although Microbot Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Microbot Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Microbot Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Income Before Tax-10.7 M-11.3 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.